We have also seen a marked improvement in the mind-body communicative markers, which is indicated by increased levels of BDNF, DHEAS, β endorphins, and sirtuin-1, followed by 8 weeks of YBLI in RA patients. The gene discussed is SULT2A1; the disease is rheumatoid arthritis.